Ahead of the Curves
Post-Covid what does the future of healthcare look like?
Nick Moore is the Managing Director, Biopharma, Healthcare, Stifel and has more than 20 years’ experience in the Healthcare industry. He trained originally as a medical doctor at Cambridge University and Harvard Medical School. In December 2013, Nicholas was named as one of the Top 40 Under 40 Rising Stars in Investment Banking by Financial News, partly in recognition of the more than 20 equity capital markets transactions he completed in 2013 alone. Since mid-2013, Nicholas has focused on raising equity capital for European healthcare companies, especially those companies in the biopharma subsector targeting investment from U.S.-based healthcare specialist investors.
In this wide-ranging podcast interview he talks about the effects of the covid pandemic, how you learn to back winners within healthcare, the profound changes coming down the line in the practice of medicine and the gulf between research and getting new treatments to the patient.